The GROWTH consortium, funded by the European Commission (2019-2023), is made up to train a new generation of researchers working on new pathological insights, biomarker diagnostics and personalized nutritional interventions for intestinal failure in neonates and preterm infants.
Academic and industry partners, covering various disciplines ranging from fundamental research to clinical paediatrics and analytical chemistry to organoid and gut-on-chip applications, have teamed up in the European Union.
GROWTH aims to set-up a new European platform that trains young scientists in the industry-led exploration of innovative routes to fully exploit the potential of early life nutrition to prevent inflammatory disease. GROWTH coordinates 8 individual research projects.
If you have any questions you can fill in the form or mail us directly: email@example.com.
Nancy Deianavo, ESR-4 in the GROWTH programme, presented her results at the annual ESPHGAN meeting. Part of her project focuses on antibiotics and necrotizing enterocolitis and sepsis in a preterm Dutch/Belgian cohort where non-exposure was associated with higher odds for disease.
Thu, 30 June